1) Vousden KH:p53:death star. Cell 103:691-694,2000
2) Levine AJ:p53, the cellular gatekeeper for growth and division. Cell 88:323-331,1997
3) Levine AJ, Momand J, Finlay CA:The p53 tumour suppressor gene. Nature 351:453-456,1991
4) Vogelstein B, Kinzler KW:p53 function and dysfunction. Cell 70:523-526,1992
5) Soussi T, Legros Y, Lubin R, et al:Multifactorial analysis of p53 alteration in human cancer:a review. Int J Cancer 57:1-9,1994
6) Crawford LV, Pim DC, Bulbrook RD:Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30:403-408,1982
7) Lubin R, Zalcman G, Bouchet L, et al:Serum p53 antibodies as early markers of lung cancer. Nat Med 1:701-702,1995
8) Shimada H, Nabeya Y, Okazumi S, et al:Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma. Surgery 132:41-47,2002
9) Shiota G, Ishida M, Noguchi N, et al:Circulating p53 antibody in patients with colorectal cancer. Dig Dis Sci 45:122-128,2000
10) Nakajima K, Shimada H, Takeda A, et al:Ditection of preoperative serum anti-p53 antibodies in gastric cancer. Tumor Biol 20:147-152,1999
11) Shimada H, Ochiai T, Nomura F:Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors:a multiinstitutional analysis by the Japan p53 Antibody Research Group. Cancer 97:682-689,2003
12) Borresen-Dale AL:TP53 and breast cancer. Hum Mutat 21:292-300,2003
13) Molina R, Barak V, van Dalen A, et al:Tumor markers in breast cancer- European Group on Tumor Markers recommendations. Tumour Biol 26:281-293,2005
14) 加藤優子,木田沙緒里,大矢和彦,他:血清抗p53抗体の乳癌症例における測定意義.日本臨床自動化学会会誌 第36巻第2号,2011掲載予定